{
  "image_filename": "table_p13_det_12_007.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p13_det_12_007.png",
  "image_type": "Table",
  "page_number": 13,
  "block_id": "det_12_007",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Excerpt of a table listing inactivated quadrivalent influenza vaccines (Afluria Quadrivalent, Fluarix Quadrivalent, Flucelvax Quadrivalent, Fluzone Quadrivalent) with their manufacturers and dose volumes/antigen content per dose. does not support the claim because the table only lists available vaccines and dosing information and does not mention any pivotal trial comparison between Flublok and Fluarix. Note: Table excerpt does not include Flublok or trial comparator details; based solely on visible content no evidence of evaluation against Fluarix is present.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Excerpt of a table listing inactivated quadrivalent influenza vaccines (Afluria Quadrivalent, Fluarix Quadrivalent, Flucelvax Quadrivalent, Fluzone Quadrivalent) with their manufacturers and dose volumes/antigen content per dose.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only lists available vaccines and dosing information and does not mention any pivotal trial comparison between Flublok and Fluarix.",
    "confidence_notes": "Table excerpt does not include Flublok or trial comparator details; based solely on visible content no evidence of evaluation against Fluarix is present."
  }
}